AMN Healthcare (NYSE: AMN) CFO reports RSU vesting, tax withholding and new grant

Rhea-AI Filing Summary

AMN Healthcare Services CFO/COO Brian M. Scott reported equity compensation activity on January 15, 2026. He acquired 8,843 shares of common stock at $0 upon vesting of Restricted Stock Units and then had 3,592 shares of common stock withheld at $19.55 per share to cover taxes, leaving him with 13,093 shares of common stock held directly.

On the derivative side, 8,843 Restricted Stock Units were converted into common stock, after which he held 17,956 Restricted Stock Units from an award granted under the AMN Healthcare 2017 Equity Plan that vests over three years. He also received a new grant of 40,920 Restricted Stock Units under the AMN Healthcare 2025 Equity Plan, bringing his total Restricted Stock Units to 81,840, each representing a contingent right to one share of AMN common stock and vesting in three annual tranches.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scott Brian M.

(Last) (First) (Middle)

12400 HIGH BLUFF DRIVE, SUITE 500

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO/COO

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M(1)		8,843	A	$0	16,685	D
Common Stock	01/15/2026		F(2)		3,592	D	$19.55	13,093	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	01/15/2026		M			8,843	(4)	(5)	Common Stock	8,843	$0	17,956	D
Restricted Stock Units	(6)	01/15/2026		A		40,920		(7)	(5)	Common Stock	40,920	$0	81,840	D

Explanation of Responses:

1. Common stock acquired on the vesting of Restricted Stock Units.

2. Number of shares withheld for tax purposes.

3. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

4. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

5. Restricted Stock Units do not have an expiration date.

6. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

7. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

Remarks:

	/s/ Brian M. Scott	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AMN (AMN) CFO/COO Brian M. Scott report on January 15, 2026?

Brian M. Scott reported that 8,843 Restricted Stock Units vested and were converted into 8,843 shares of AMN common stock at $0 per share. He also reported a new grant of 40,920 Restricted Stock Units on the same date.

How many AMN (AMN) common shares does the CFO/COO hold after this Form 4?

Following the reported transactions, Brian M. Scott beneficially owned 13,093 shares of AMN common stock directly.

How many Restricted Stock Units does the AMN (AMN) CFO/COO hold after the reported transactions?

After the vesting and new grant on January 15, 2026, Brian M. Scott held 17,956 Restricted Stock Units from a prior grant and 81,840 Restricted Stock Units in total.

What was the purpose of the 3,592 AMN (AMN) shares reported as disposed of?

The 3,592 shares of AMN common stock disposed of at $19.55 per share were withheld for tax purposes in connection with the vesting of Restricted Stock Units.

Under which equity plans were the AMN (AMN) Restricted Stock Units granted to the CFO/COO?

The Form 4 notes that certain Restricted Stock Units were granted under the AMN Healthcare 2017 Equity Plan and a new award was granted under the AMN Healthcare 2025 Equity Plan, with each unit representing a contingent right to one share of AMN common stock.

How do the AMN (AMN) Restricted Stock Units reported by the CFO/COO vest over time?

The filing states that the Restricted Stock Units granted on January 15, 2025 and January 15, 2026 each vest in three tranches on the first, second, and third anniversaries of the grant date, subject to the grantee providing three periods of credited service.